Page last updated: 2024-08-21

erythromycin and Hypertrophy

erythromycin has been researched along with Hypertrophy in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's1 (7.69)18.2507
2000's10 (76.92)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayakawa, K; Hiraoka, M; Kobata, R; Mayumi, M; Shiima, Y; Tsukahara, H1
Amsden, GW; Hauben, M1
Hoey, J1
García Martín, FJ; Milano Manso, G; Oliva Rodríguez-Pastor, S1
Kleiman, MB; Mahon, BE; Rosenman, MB1
Sondheimer, JM1
Arbogast, P; Cooper, WO; Gautam, S; Griffin, MR; Hickson, GB; Ray, WA1
Cooper, WO; Griffin, MR; Ray, WA1
SanFilippo, A1
Stang, H1

Reviews

1 review(s) available for erythromycin and Hypertrophy

ArticleYear
The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?
    Drug safety, 2002, Volume: 25, Issue:13

    Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Cohort Studies; Databases, Factual; Digestive System; Erythromycin; Female; Gastrointestinal Motility; Humans; Hypertrophy; Infant; Infant, Newborn; Male; Pyloric Stenosis; Retrospective Studies

2002

Other Studies

12 other study(ies) available for erythromycin and Hypertrophy

ArticleYear
Erythromycin in ELBW infants.
    The Journal of pediatrics, 2002, Volume: 141, Issue:2

    Topics: Chronic Disease; Erythromycin; Humans; Hypertrophy; Infant Welfare; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Lung Diseases; Male; Pyloric Stenosis; Treatment Failure

2002
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.
    MMWR. Morbidity and mortality weekly report, 1999, Dec-17, Volume: 48, Issue:49

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cluster Analysis; Cohort Studies; Erythromycin; Humans; Hypertrophy; Infant; Infant, Newborn; Infectious Disease Transmission, Professional-to-Patient; Pyloric Stenosis; Tennessee; Whooping Cough

1999
From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.
    JAMA, 2000, Jan-26, Volume: 283, Issue:4

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cluster Analysis; Cohort Studies; Erythromycin; Humans; Hypertrophy; Infant; Infant, Newborn; Infectious Disease Transmission, Professional-to-Patient; Pyloric Stenosis; Tennessee; Whooping Cough

2000
Erythromycin use linked to pyloric stenosis.
    The American journal of nursing, 2000, Volume: 100, Issue:3

    Topics: Anti-Bacterial Agents; Erythromycin; Humans; Hypertrophy; Infant, Newborn; Pyloric Stenosis

2000
Hypertrophic pyloric stenosis caused by erythromycin.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Apr-18, Volume: 162, Issue:8

    Topics: Anti-Bacterial Agents; Disease Outbreaks; Erythromycin; Female; Humans; Hypertrophy; Infant, Newborn; Kentucky; Male; Pyloric Stenosis; Whooping Cough

2000
[Erythromycin and hypertrophic stenosis of the pylorus].
    Anales espanoles de pediatria, 2001, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Erythromycin; Humans; Hypertrophy; Infant, Newborn; Male; Pyloric Stenosis

2001
Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.
    The Journal of pediatrics, 2001, Volume: 139, Issue:3

    Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Hypertrophy; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pyloric Stenosis; Retrospective Studies; Risk Factors

2001
A question that won't go away.
    Journal of pediatric gastroenterology and nutrition, 2002, Volume: 34, Issue:2

    Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Hypertrophy; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pyloric Stenosis; Retrospective Studies

2002
Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.
    Archives of pediatrics & adolescent medicine, 2002, Volume: 156, Issue:7

    Topics: Anti-Bacterial Agents; Cohort Studies; Erythromycin; Female; Gastrointestinal Agents; Humans; Hypertrophy; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infections; Male; Pyloric Stenosis; Pylorus; Retrospective Studies; Risk Factors; Tennessee; Time Factors

2002
Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
    Obstetrics and gynecology, 2002, Volume: 100, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Confidence Intervals; Erythromycin; Female; Gestational Age; Humans; Hypertrophy; Incidence; Infant, Newborn; Odds Ratio; Pregnancy; Prenatal Care; Probability; Pyloric Stenosis; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sex Distribution; Tennessee

2002
Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.
    Journal of pediatric surgery, 1976, Volume: 11, Issue:2

    Topics: Erythromycin; Erythromycin Estolate; Female; Humans; Hypertrophy; Infant, Newborn; Male; Pyloric Stenosis; Retrospective Studies; Time Factors

1976
Pyloric stenosis associated with erythromycin ingested through breastmilk.
    Minnesota medicine, 1986, Volume: 69, Issue:11

    Topics: Adult; Erythromycin; Female; Humans; Hypertrophy; Infant; Male; Milk, Human; Pyloric Stenosis; Retrospective Studies

1986